Concepedia

Daniel Stadlbauer

DS

49

Publications

9.1K

Citations

33

H-Index

2000

Active since

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

BOKU University

Moderna Therapeutics (United States)

Washington University in St. Louis

Scripps Research Institute

Daniel Stadlbauer is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, immunology, and virology.

ORCID

Top concepts

Publications per year

2000–2024

49

Publications

49

A serological assay to detect SARS-CoV-2 seroconversion in humans

Fatima Amanat, Daniel Stadlbauer, Shirin Strohmeier et al. · Nature Medicine · 2020 · 1.9K citations · Full text

, , +3

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

Ania Wajnberg, Fatima Amanat, Adolfo Firpo et al. · Science · 2020 · 1.2K citations · Full text

SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup

Daniel Stadlbauer, Fatima Amanat, Veronika Chromikova et al. · Current Protocols in Microbiology · 2020 · 805 citations · Full text

, , +18

Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine

Florian Krammer, Komal Srivastava, Hala Alshammary et al. · New England Journal of Medicine · 2021 · 793 citations · Full text

, , +11

Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study

Sean Liu, Hung-Mo Lin, Ian Baine et al. · Nature Medicine · 2020 · 493 citations · Full text

Rows per page

1–5 of 49